June 27, 2025

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a Promising 206% Upside with Strong Buy Ratings

Tyra Biosciences, Inc. (TYRA), a clinical-stage biotechnology company, stands out in the healthcare sector with a market capitalization of $522.74 million. As an innovative player in..

Owens & Minor, Inc. (OMI)

⚠️ No article content returned.

..

Auna SA (AUNA) Stock Analysis: Healthcare Leader with a 99% Upside Potential

For investors eyeing opportunities in the healthcare sector, Auna S.A. (AUNA) presents a compelling case. Operating hospitals and clinics across Mexico, Peru, and Colombia, Auna is..

Neuropace, Inc. (NPCE) Stock Analysis: A 56% Potential Upside Awaits Investors

Neuropace, Inc. (NPCE), a trailblazer in the healthcare sector, specifically within the medical devices industry, stands out with its innovative approach to treating drug-resistant focal epilepsy...

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Eyeing a 248.78% Potential Upside in the Biotech Sector

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a promising player in the biotechnology sector, is capturing investor attention with a staggering potential upside of 248.78%. As a late-stage..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Unlocking 121.77% Potential Upside in Biotechnology

Praxis Precision Medicines, Inc (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, has been gaining attention in the biotechnology sector with its focus on developing therapies for central..

Arbutus Biopharma (ABUS) Investor Outlook: Unpacking a Potential 67% Upside in the Healthcare Innovator

Arbutus Biopharma Corporation (NASDAQ: ABUS) has positioned itself as a noteworthy contender in the biotechnology sector, with a specific focus on developing innovative treatments for infectious..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Healthcare with a 21% Upside Potential

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the U.S. healthcare sector, is currently capturing investor attention with its intriguing mix of performance metrics..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Biotechnology’s Visionary with 47.79% Potential Upside

Investors with an eye for promising biotech ventures may find LENZ Therapeutics, Inc. (NASDAQ: LENZ) a compelling addition to their portfolios. This Solana Beach-based company is..

Immatics N.V. (IMTX) Stock Analysis: Exploring a 156% Potential Upside in the Biotech Arena

Immatics N.V. (NASDAQ: IMTX) stands at a pivotal juncture in the biotechnology sector, capturing investor attention with a potential upside of 156.41%. Specializing in the development..

Embecta Corp. (EMBC): Investor Outlook on a 91% Potential Upside

Embecta Corp. (NASDAQ: EMBC), a key player in the healthcare sector, is capturing the attention of investors with its significant potential upside of 91.27%. Specializing in..

CureVac N.V. (CVAC) Investor Outlook: Navigating the mRNA Pioneer Amidst a Challenging Market Landscape

CureVac N.V. (NASDAQ: CVAC) stands at the forefront of biopharmaceutical innovation, harnessing the transformative potential of messenger RNA (mRNA) technologies. Headquartered in Tübingen, Germany, CureVac focuses..

RxSight, Inc. (RXST) Investor Outlook: Analyzing the 60% Potential Upside Amid a Volatile Market

RxSight, Inc. (NASDAQ: RXST) stands as a compelling investment option in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $537.63..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Exploring a Potential 332% Upside for Investors

Day One Biopharmaceuticals, Inc (NASDAQ: DAWN) has captured the attention of investors in the biotechnology sector with its promising pipeline and significant potential for stock appreciation...

Oculis Holding AG (OCS) Stock Analysis: Biotech Innovator with a 96.67% Upside Potential

Oculis Holding AG (NASDAQ: OCS), a promising player in the biotechnology sector, is gaining attention from investors with its cutting-edge approach to treating ophthalmic diseases. Based..

Geron Corporation (GERN) Stock Analysis: Exploring a Potential 141% Upside in the Biotech Arena

Geron Corporation (NASDAQ: GERN) is making waves in the biotechnology sector, primarily due to its ambitious focus on oncology therapeutics. Specializing in telomerase inhibitors, this commercial-stage..

CareDx, Inc. (CDNA) Stock Analysis: Exploring a 51.82% Upside Potential in the Healthcare Diagnostics Sector

CareDx, Inc. (CDNA), a prominent player in the healthcare diagnostics and research industry, is gaining attention from the investment community due to its innovative transplant-focused solutions..

CorMedix Inc. (CRMD) Investor Outlook: Analyzing 25.89% Potential Upside with Strong Buy Ratings

CorMedix Inc. (CRMD), a promising player in the biotechnology sector, has been gaining attention from investors, thanks to its focus on addressing critical healthcare needs with..

Delcath Systems, Inc. (DCTH) Stock Analysis: A Promising 71% Upside in the Healthcare Sector

Delcath Systems, Inc. (NASDAQ: DCTH) is generating buzz in the healthcare sector with its innovative approach to treating liver cancers. Operating within the medical devices industry,..

GH Research PLC (GHRS) Stock Analysis: Exploring a Potential 167% Upside with Innovative Depression Treatments

Investors looking for opportunities in the biotechnology sector should take a closer look at GH Research PLC (GHRS), an Irish clinical-stage biopharmaceutical company that is making..

Search

Funds

June 27, 2025

Search

Funds

June 27, 2025

FTSE 100

Funds